@FierceBiotech: PathoGenetix raises $7.5M in second closing of series B financing for rapid bacterial identification system. Story | Follow @FierceBiotech
@JohnCFierce: Exelixis has always had problems with study designs; source of issue with BMS. Fight the FDA, though? Shares tank. Item | Follow @JohnCFierce
@RyanMFierce: U.K. trial aims to test use of agents to make tricky brain tumors glow to aid surgical removal. Makes sense. Report | Follow @RyanMFierce
@MaureenFierce: Sanofi set to rev past Pfizer in pharma rankings. Article | Follow @MaureenFierce
> Boulder, CO-based Clovis Oncology, which is preparing for an IPO, has priced its shares between $13 and $15. Article
> In the U.K., researchers are kicking off a trial of a compound that will cause brain tumors to glow, making it easier for surgeons to identify and remove the growths. Sixty glioblastoma patients will participate in the study. Report
> GSK and Alnylam Pharmaceuticals have inked a deal for to use Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. Financial details were not disclosed. Release
> The Foundation Fighting Blindness has invested $8.25 million in 6 new gene therapy research projects that are targeted to have treatments ready for clinical trials within three years. Release
> H3 Biomedicine has named Dr. Markus Warmuth CEO, effective immediately. Release
> Women in Bio is opening a Boston chapter of the organization, its first in the Northeast. Report
Pharma News
@FiercePharma: Dutch researchers are comparing GSK's Advair Diskus with a rival device in a study funded by $GSK. Item | Follow @FiercePharma
> Additional data sways NICE in favor of Pradaxa. Article
Biotech Research News
> Jackson Lab ready to start hiring for new genetics center. Item
> Caltech team designs a new and improved HIV antibody. Article
> Court ruling could derail ambitious stem cell program for synthetic blood. Report
> Investigators tout a new therapeutic approach to cardiovascular disease. News
Manufacturing News
> Ranking: Baxter, J&J lead green pharma companies. News
> Researchers tout big increase in heparin yield. Report
> KV Pharma, ex-CEO battle over recall responsibility. Item
> Closures a sign of Novartis minimizing production in Switzerland. Report
> Obama takes aim at drug shortages. News
And Finally... Why Steve Jobs' magic doesn't work in medicine. Article